Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., May 23, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company...
Month: May 2022
Relief Therapeutics Expands U.S. Commercial Team
Tracy Truong and Kelli Powell Appointed Regional Clinical Specialists for the West and Northeast Regions, RespectivelySeasoned Account Managers Bring Extensive...
Dr. Jon Wilhelm of Pro Chiropractic has Attended the Mt Sac Relays for the 4th Consecutive Year
BOZEMAN, MT / ACCESSWIRE / May 20, 2022 / For the fourth consecutive year, sports chiropractor Dr. Jon Wilhelm has...
IIOT-OXYS, Inc. Signs NDA with EU Smart Automation Technology Start-Up
CAMBRIDGE, MA / ACCESSWIRE / May 20, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) (the "Company") announces the execution of a...
AgriCann Solutions Announces Conversion of Convertible Debenture Debt into Equity
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2022) - AgriCann Solutions Corp. (the "Company" or "AgriCann"), is pleased to announce...
Norwegian Seafood Council Selects Padilla as U.S. Public Relations AOR
Agency’s creativity, passion and deep expertise in food importer, distributor, retailer and food-service channel marketing set it apart MINNEAPOLIS--(BUSINESS WIRE)--#AOR--Following...
uPerform Joins AWS Partner Network
uPerform achieves APN Advanced Tier Member designation for its expertise with AWS ELKRIDGE, Md.--(BUSINESS WIRE)--#uPerform--uPerform the market-leading just-in-time training and...
Rushnet, Inc Announces Debt Restructuring to Greatly Increase Profitability and Cash Flow
ALPHARETTA, GA / ACCESSWIRE / May 20, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce the...
Altamira Therapeutics Announces Positive Top-line Results from its Clinical Trial with Bentrio Nasal Spray in House Dust Mite Study
Company's drug-free nasal spray demonstrated a statistically significant reduction of nasal symptoms vs. untreated controls as well as good tolerability...
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at...
TransCode Therapeutics To Participate at H.C. Wainwright Global Investment Conference
BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at...
InvestmentPitch Media Video Discusses Reliq Health, a Rapidly Growing Global Telemedicine Company, Goes Live with First Clinical Trials This Month and Signs Four New Contracts in Texas and Florida
VANCOUVER, British Columbia, May 20, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
ProKidney to present at upcoming investor conferences
WINSTON-SALEM, N.C., May 20, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the...
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program
Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board...
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals
Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends...
Radius Adds Industry Veterans Jennifer A. Jarrett and Susan Vissers Lisa to Board of Directors
Further Expands Board’s Expertise and Gender Diversity Enhances Corporate Governance BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc....
VYRA™ Product Line Update
HALIFAX, Nova Scotia, May 20, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the...
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold as YONDELIS ® by Janssen, a Johnson & Johnson Company) in Connective Tissue Cancer Soft Tissue Sarcoma Mice Study
ImmixBio IMX-110 Demonstrated Improved Survival Over U.S. Food and Drug Administration Approved Drug Trabectedin (sold as YONDELIS ® by Janssen,...
Novartis Cosentyx® (secukinumab) receives positive CHMP opinion for expanded use in childhood arthritic conditions
Positive opinion could expand the role of Cosentyx® (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic...
TOMI to Attend the INTERPHEX 2022 Technical Conference
FREDERICK, Md., May 20, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection...